Abstract
Based on the natural ability of coronaviruses to undergo homologous RNA recombination, we are working to produce infectious bronchitis virus (IBV) recombinants using RNA generated from recombinant fowlpox viruses (FPV). The aim is to replace the spike (S) gene of an existing IBV vaccine strain with the S gene of a heterologous strain. CD-61 is an IBV defective RNA (D-RNA) derived from a naturally occurring IBV D-RNA(CD-91). CD-61 D-RNA is being investigated as an RNA vector for the expression of heterologous genes. T7-derived RNA transcripts of CD-61 can be replicated and passaged in the presence of helper virus, following electroporation into IBV-infected cells. CD-61 cDNA was modified by the addition of the hepatitis delta virus ribozyme plus T7 terminator downstream of the 3’ UTR. This allowed the synthesis of discreet RNA transcripts. The complete cassette was cloned into an FPV transfer vector (pEFL10) for generating recombinant fowlpox viruses. FPV/CD-61 recombinants will be assessed for D-RNA production in IBV-infected cells. The luciferase reporter gene sequence has been inserted into the modified CD-61, under the control of the IBV transcription associated sequence (TAS) from gene 5. Luciferase has been successfully expressed from CD-61 in helper virus-infected cells.
Chapter PDF
Similar content being viewed by others
Keywords
- Infectious Bronchitis Virus
- Heterologous Gene Expression
- Infectious Bronchitis Virus Strain
- Chicken Embryo Fibroblast Cell
- Fowlpox Virus
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Britton, P., Green, P., Kottier, S., Mawditt, K. L., Pénzes, Z., Cavanagh, D. and Skinner, M. A., 1996, Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus, J. Gen. Virol. 77:963–967.
Cavanagh, D., 1983, Coronavirus IBV: structural characterisation of the spike protein, J. Gen. Virol. 64:2577–2583.
Kottier, S. A., Cavanagh, D. and Britton, P., 1995, Experimental evidence of recombination in coronavirus infectious bronchitis virus, Virology 213:569–580.
Pénzes, Z., Tibbies, K., Shaw, K., Britton, P., Brown, T.D.K. and Cavanagh, D., 1994, Characterisation of a replicating and packaged defective RNA of avian coronavirus infectious bronchitis virus, Virology 203:286–293.
Pénzes, Z., Wroe, C., Brown, T.D.K., Britton, P. and Cavanagh, D., 1996, Replication and packaging of coronavirus infectious bronchitis virus defective RNAs lacking a long open reading frame, J. Virol. 70(12):8660–8668.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Evans, S.A., Stirrups, K., Dalton, K., Shaw, K., Cavanagh, D., Britton, P. (1998). Utilising a Defective IBV RNA for Heterologous Gene Expression with Potential Prophylactic Application. In: Enjuanes, L., Siddell, S.G., Spaan, W. (eds) Coronaviruses and Arteriviruses. Advances in Experimental Medicine and Biology, vol 440. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5331-1_88
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5331-1_88
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7432-9
Online ISBN: 978-1-4615-5331-1
eBook Packages: Springer Book Archive